Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karo Pharma AB buy UBS Group AG

Start price
€5.44
30.08.25 / 50%
Target price
-
30.08.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 30.08.26. The prediction end date can be changed by UBS_Group_AG at any time.
Performance without dividends (%)
Name 1w
Karo Pharma AB -
iShares Core DAX® -1.740%
iShares Nasdaq 100 -0.157%
iShares Nikkei 225® -1.705%
iShares S&P 500 0.148%

Comments by UBS_Group_AG for this prediction

In the thread Karo Pharma AB diskutieren

Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Ratings data for KARO provided by MarketBeat